Filing Flows

Filing Flows › Biodesix (BDSX) › How it makes money

How Biodesix (BDSX) makes money

Biodesix (BDSX) made $24.0M of revenue in the third quarter 2026 (Q3 2026), +10% from a year earlier. Diagnostic Tests brought in $23.1M (96%); Development Services brought in $986K (4%).

Drawing the Sankey…

Biodesix revenue by segment, Q3 2026Biodesix revenue by segment, Q3 2026Diagnostic Tests$23.1MDevelopment Services$986K
Biodesix: revenue by line, Q1 2025 to Q3 2026Biodesix: revenue by line, Q1 2025 to Q3 2026Diagnostic TestsDevelopment ServicesDiagnostic Tests: $23.1M latest$23.1MDevelopment Services: $986K latestQ1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026
Development Services went from 9% of revenue in Q1 2025 to 4% in Q3 2026, the largest shift in the mix.
Biodesix revenue by quarterBiodesix revenue by quarter$18.0MQ1 2025$20.0MQ2 2025$21.8MQ3 2025$28.8MQ4 2025$25.6MQ1 2026$26.9MQ2 2026$24.0MQ3 2026

Revenue by segment, Q3 2026

SegmentRevenueShareQ/QY/Y
Diagnostic Tests$23.1M95.9%-9%+16%
Development Services$986K4.1%-35%-49%

Where each dollar of revenue goes

LineQ3 2026% of revenue
Revenue$24.0M100.0%

Revenue, quarter by quarter

QuarterRevenueY/Y
Q3 2026$24.0M+10%
Q2 2026$26.9M+34%
Q1 2026$25.6M+42%
Q4 2025$28.8M+41%
Q3 2025$21.8M+20%
Q2 2025$20.0M+12%
Q1 2025$18.0M+21%

From Biodesix's 10-Q filed Nov 5, 2026 (on EDGAR).

Questions

How does Biodesix make money?

Biodesix (BDSX) made $24.0M of revenue in the third quarter 2026 (Q3 2026), +10% from a year earlier. Diagnostic Tests brought in $23.1M (96%); Development Services brought in $986K (4%).

What is Biodesix's biggest business?

Diagnostic Tests: $23.1M in the third quarter 2026, 96% of revenue, +16% from a year earlier.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.